Please try another search
Horizon Pharmaceutical LLC operates as a biopharmaceutical company that focuses on developing and commercializing drug candidates for the treatment of nephropathic cystinosis diseases. It offers products for Huntington’s, nonalcoholic fatty liver, and Leigh syndrome and other mitochondrial diseases; ALDH2 deficiency needs; and hepatocellular carcinoma treatments. The company also provides inhibitors for human enzyme cysteamine dioxygenase treatments. It serves customers in the United States and internationally. Horizon Pharmaceutical LLC was formerly known as Raptor Pharmaceutical Corporation and changed its name to Horizon Pharmaceutical LLC in October 2016. The company was founded in 2005 and is headquartered in Novato, California with operations worldwide. As of October 24, 2016, Horizon Pharmaceutical LLC operates as a subsidiary of Horizon Pharma Public Limited Company.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review